Table 4.
Detailed Expression of DSG3 in All Positive Cases
Organ | Tumor type | DSG3 (+) (N) | Positive cells (%)
|
|
---|---|---|---|---|
Mean | Range | |||
Lung | SQCC | 64 | 59.8 | 5–100 |
Lung | AD | 1 | <5 | 5 |
Lymph node | SQCC | 19 | 80.4 | 5–100 |
Skin | SQCC | 12 | 91.8 | 70–100 |
Head-Neck | SQCC | 5 | 93.6 | 90–98 |
Head-Neck | Mucoepidermoid ca | 4 | 87.5 | 30–85 |
Head-Neck | Adenoid cystic ca | 7 | 17.8 | 5–60 |
Breast | AD | 1 | 70 | 70 |
Tonsil | SQCC | 10 | 74.4 | 5–100 |
Tongue | SQCC | 8 | 85.6 | 30–100 |
Larynx | SQCC | 9 | 86.9 | 30–100 |
Thymus | Thymoma | 2 | 25 | 10–40 |
Esophagus | SQCC | 15 | 59.7 | 5–100 |
Stomach | AD | 1 | 10 | 10 |
Pancreas | AD | 8 | 16.8 | 5–75 |
Colon | AD | 5 | 24 | 5–40 |
Anus | SQCC | 4 | 82 | 20–98 |
Bladder | Transitional cell ca | 3 | 58.3 | 5–90 |
Vulva | SQCC | 9 | 81.4 | 10–100 |
Cervix | SQCC | 9 | 75.6 | 60–100 |
Ovary | AD | 1 | <5 | 5 |
SQCC = squamous cell carcinoma; AD = adenocarcinoma; ca = carcinoma.